{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:35:49Z","timestamp":1781498149243,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11154-024-09927-4","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T07:06:54Z","timestamp":1732000014000},"page":"995-1002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Reference intervals for serum prolactin concentrations: analytical and clinical considerations"],"prefix":"10.1007","volume":"25","author":[{"given":"Kate","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"9927_CR1","doi-asserted-by":"crossref","unstructured":"Freeman ME et al. Prolactin: structure, function, and regulation of secretion. Physiological reviews, 2000.","DOI":"10.1152\/physrev.2000.80.4.1523"},{"issue":"3","key":"9927_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","volume":"19","author":"C Bole-Feysot","year":"1998","unstructured":"Bole-Feysot C, et al. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19(3):225\u201368.","journal-title":"Endocr Rev"},{"issue":"1","key":"9927_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","volume":"64","author":"V Goffin","year":"2002","unstructured":"Goffin V, et al. Prolactin: the new biology of an old hormone. Annu Rev Physiol. 2002;64(1):47\u201367.","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"9927_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.4158\/EP15938.DSC","volume":"21","author":"S Samson","year":"2015","unstructured":"Samson S, Hamrahian AH, Ezzat S. American Association of Clinical Endocrinologists, American College of Endocrinology Disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia. Endocr Pract. 2015;21(12):1427\u201335.","journal-title":"Endocr Pract"},{"issue":"5","key":"9927_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","volume":"27","author":"M Fahie-Wilson","year":"2013","unstructured":"Fahie-Wilson M, Smith TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab. 2013;27(5):725\u201342.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"9927_CR6","first-page":"1338","volume":"75","author":"T Brue","year":"1992","unstructured":"Brue T, et al. Immunoradiometric analysis of circulating human glycosylated and nonglycosylated prolactin forms: spontaneous and stimulated secretions. J Clin Endocrinol Metabolism. 1992;75(5):1338\u201344.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"6","key":"9927_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1258\/acb.2009.009059","volume":"46","author":"N Jassam","year":"2009","unstructured":"Jassam N, et al. Macroprolactin on the Advia Centaur: experience with 409 patients over a three-year period. Ann Clin Biochem. 2009;46(6):501\u20134.","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"9927_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2265.2005.02243.x","volume":"62","author":"J Gibney","year":"2005","unstructured":"Gibney J, Smith TP, McKenna TJ. Clinical relevance of macroprolactin. Clin Endocrinol. 2005;62(6):633\u201343.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"9927_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2265.2009.03577.x","volume":"71","author":"T Joseph McKenna","year":"2009","unstructured":"Joseph McKenna T. Should macroprolactin be measured in all hyperprolactinaemic sera? Clin Endocrinol. 2009;71(4):466\u20139.","journal-title":"Clin Endocrinol"},{"key":"9927_CR10","unstructured":"Al-Chalabi M, Bass AN, Alsalman I. Physiology, prolactin. 2018."},{"issue":"18","key":"9927_CR11","doi-asserted-by":"publisher","first-page":"13337","DOI":"10.1016\/S0021-9258(17)36838-2","volume":"269","author":"M Nagano","year":"1994","unstructured":"Nagano M, Kelly PA. Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J Biol Chem. 1994;269(18):13337\u201345.","journal-title":"J Biol Chem"},{"issue":"5","key":"9927_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2015.36","volume":"11","author":"V Bernard","year":"2015","unstructured":"Bernard V, et al. New insights in prolactin: pathological implications. Nat Reviews Endocrinol. 2015;11(5):265\u201375.","journal-title":"Nat Reviews Endocrinol"},{"key":"9927_CR13","doi-asserted-by":"crossref","unstructured":"Samperi I, Lithgow K, Karavitaki N. Hyperprolactinaemia J Clin Med. 2019;8(12):2203.","DOI":"10.3390\/jcm8122203"},{"issue":"12 Suppl","key":"9927_CR14","first-page":"1075","volume":"44","author":"B Biller","year":"1999","unstructured":"Biller B, et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med. 1999;44(12 Suppl):1075\u201384.","journal-title":"J Reprod Med"},{"issue":"1","key":"9927_CR15","first-page":"3","volume":"39","author":"M Saleem","year":"2018","unstructured":"Saleem M, Martin H, Coates P. Prolactin biology and laboratory measurement: an update on physiology and current analytical issues. Clin Biochemist Reviews. 2018;39(1):3.","journal-title":"Clin Biochemist Reviews"},{"issue":"1","key":"9927_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000499694","volume":"109","author":"L Vilar","year":"2019","unstructured":"Vilar L, et al. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology. 2019;109(1):7\u201319.","journal-title":"Neuroendocrinology"},{"issue":"2","key":"9927_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine Society clinical practice guideline. J Clin Endocrinol Metabolism. 2011;96(2):273\u201388.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"9927_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11154-015-9322-3","volume":"16","author":"G Rastrelli","year":"2015","unstructured":"Rastrelli G, Corona G, Maggi M. The role of prolactin in andrology: what is new? Reviews Endocr Metabolic Disorders. 2015;16:233\u201348.","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"10","key":"9927_CR19","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1373\/clinchem.2008.105312","volume":"54","author":"L Beltran","year":"2008","unstructured":"Beltran L, et al. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms. Clin Chem. 2008;54(10):1673\u201381.","journal-title":"Clin Chem"},{"key":"9927_CR20","doi-asserted-by":"crossref","unstructured":"De Sousa SM, et al. Serum prolactin overestimation and risk of misdiagnosis. Diabetes Metab. 2019;2(3):e00065. Endocrinology.","DOI":"10.1002\/edm2.65"},{"issue":"7","key":"9927_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2362.2007.01823.x","volume":"37","author":"F Donadio","year":"2007","unstructured":"Donadio F, et al. Patients with macroprolactinaemia: clinical and radiological features. Eur J Clin Invest. 2007;37(7):552\u20137.","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"9927_CR22","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1515\/cclm-2016-0902","volume":"55","author":"M Overgaard","year":"2017","unstructured":"Overgaard M, Pedersen SM. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia. Clin Chem Lab Med (CCLM). 2017;55(11):1744\u201353.","journal-title":"Clin Chem Lab Med (CCLM)"},{"issue":"3","key":"9927_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1258\/0004563053857969","volume":"42","author":"M Fahie-Wilson","year":"2005","unstructured":"Fahie-Wilson M, John R, Ellis A. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem. 2005;42(3):175\u201392.","journal-title":"Ann Clin Biochem"},{"issue":"5\u20136","key":"9927_CR24","first-page":"301","volume":"53","author":"M Fahie-Wilson","year":"2007","unstructured":"Fahie-Wilson M, et al. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol. Clin Lab. 2007;53(5\u20136):301\u20137.","journal-title":"Clin Lab"},{"issue":"12","key":"9927_CR25","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1210\/jc.2001-011943","volume":"87","author":"TP Smith","year":"2002","unstructured":"Smith TP, et al. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metabolism. 2002;87(12):5410\u20135.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"7","key":"9927_CR26","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1373\/clinchem.2005.065854","volume":"52","author":"L Kavanagh","year":"2006","unstructured":"Kavanagh L, et al. Specificity and clinical utility of methods for the detection of macroprolactin. Clin Chem. 2006;52(7):1366\u201372.","journal-title":"Clin Chem"},{"key":"9927_CR27","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1210\/jc.2002-021617","volume":"87","author":"J Schlechte","year":"2002","unstructured":"Schlechte J. The macroprolactin problem [editorial]. J Clin Endocrinol Metab. 2002;87:5408\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"9927_CR28","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/clinchem\/47.12.2184","volume":"47","author":"R Sapin","year":"2001","unstructured":"Sapin R, Simon C. False hyperprolactinemia corrected by the use of heterophilic antibody-blocking agent. Clin Chem. 2001;47(12):2184\u20135.","journal-title":"Clin Chem"},{"issue":"3","key":"9927_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1258\/acb.2008.007233","volume":"45","author":"S Ram","year":"2008","unstructured":"Ram S, et al. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins. Ann Clin Biochem. 2008;45(3):256\u20139.","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"9927_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1515\/cclm-2018-0073","volume":"57","author":"GRD Jones","year":"2019","unstructured":"Jones GRD, et al. Indirect methods for reference interval determination\u2013 review and recommendations. Clin Chem Lab Med (CCLM). 2019;57(1):20\u20139.","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"9927_CR31","doi-asserted-by":"crossref","unstructured":"Chincholkar P, Yeo CP, Ho CKM. Gender-specific reference intervals for serum prolactin concentrations before and after precipitation by polyethylene glycol. Proceedings of Singapore Healthcare, 2022. 31: p. 20101058211049838.","DOI":"10.1177\/20101058211049838"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09927-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-024-09927-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09927-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T15:06:57Z","timestamp":1733584017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-024-09927-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9927"],"URL":"https:\/\/doi.org\/10.1007\/s11154-024-09927-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"4 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}